The last 11 years have taught us much about the Federal Circuit; namely, that a majority of the judges simply do not seem to appreciate ...

The CRISPR-Cas9 patent landscape remains complex and unsettled. The Federal Circuit’s latest decision in University of California v.

A court ruled in favor of Acadia Pharmaceuticals in its litigation alleging patent infringement. Acadia had alleged certain abbreviated new drug application filers, including Aurobindo Pharma, had ...

The Department of Interior (DOI) in early April withdrew its opposition to the Glacier Range Riders’ arrowhead logo, drawing ...

The federal government withdrew its complaint against a Glacier Range Riders logo, ending a multi-year trademark dispute, ...

The Unified Patent Court (UPC) has quickly become an important forum for pharmaceutical and biotech patent disputes in Europe ...